Search

Search Constraints

You searched for: Author/Creator Bianchini, Giampaolo

Search Results

1. Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer. Issue 1 (December 2017)

3. Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis. (July 2021)

4. Comparison of tumor‐infiltrating lymphocytes between primary and metastatic tumors in breast cancer patients. Issue 12 (December 2016)

5. DNA Repair Gene Patterns as Prognostic and Predictive Factors in Molecular Breast Cancer Subtypes. (25th September 2013)

7. Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personalized?. (February 2021)

9. OPG and PgR show similar cohort specific effects as prognostic factors in ER positive breast cancer. Issue 7 (15th April 2014)

10. Ovarian reserve of women with and without BRCA pathogenic variants: A systematic review and meta-analysis. (December 2021)